Five home-testing devices for obstructive sleep apnoea hypopnoea syndrome (OSAHS), a potentially dangerous condition ...

Eisai and Biogen have filed a rolling biologics license application in the US for a subcutaneous formulation of Alzheimer’s ...

The US FDA has approved a human papillomavirus (HPV) self-sampling solution developed by Roche that allows patients to ...

AbbVie has joined the short list of big pharma companies that have taken a gamble on the emerging field of psychedelic ...

The latest version of ICER’s evidence report (PDF) on Lykos’ MDMA-assisted psychotherapy for PTSD points to “functional ...

Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it ...

The total headcount at the group was a little over 99,700 at the end of last year and fell to around 98,200 by the end of ...

In SELECT, semaglutide showed a 20% reduction in major adverse cardiovascular events (MACE) – including cardiovascular death, ...

Last year, MSD revealed that the co-formulation – given either alone or in combination with docetaxel chemotherapy – also ...

The fear for shareholders is that a delay could mean that mRNA-1345 won’t be ready to roll out in the US in time for the ...

Along with ACI-24.060, it is also developing a tau protein-targeting immunotherapy for Alzheimer’s (ACI-35.030) with Johnson ...

The first person to receive a transplant of a kidney from a pig has died almost two months after the procedure, although the ...